Epilepsy clinical trials at UCSD
2 in progress, 0 open to eligible people
Showing trials for
A Study of Lorcaserin as Adjunctive Treatment in Participants With Dravet Syndrome
Sorry, not currently recruiting here
The primary purpose of the study is to demonstrate that lorcaserin has superior efficacy compared to placebo on percent change in frequency of convulsive seizures per 28 days in participants with Dravet syndrome.
San Diego, California and other locations
Cenobamate Open-Label Extension Study for YKP3089C025
Sorry, accepting new patients by invitation only
52 Week Open-Label Safety Study of Cenobamate for Subjects who Complete YKP3089C025
La Jolla, California and other locations
Last updated: